IRENE PARSONSON: Open Payments
NPI 1932275286 · BROOKFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 22 payments from 9 companies in 2025. Trend: 2023 $407 · 2024 $414 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Viatris Specialty LLC | 2 | $44 |
| PFIZER INC. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: FANAPT, HETLIOZ, CAPLYTA, INGREZZA, REXULTI, YUPELRI, PREVNAR 20, SPRAVATO.
Industry payments across MO — which companies pay providers there.
